Micro-Structural Brain Alterations in Aviremic HIV+ Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Granziera, Cristina ^a,b   Daducci, Alessandro ^b   Simioni, Samanta ^a   Cavassini, Matthias ^a   Roche, Alexis ^b   Meskaldji, Djalel ^b   Kober, Tobias ^b   Metral, Melanie ^c   Calmy, Alexandra ^c   Helms, Gunther ^d   Hirschel, Bernard ^c   Lazeyras, François ^c   Meuli, Reto ^a   Krueger, Gunnar ^b,e   Du Pasquier, Renaud A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b EPFL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e Siemens Schweiz AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; VIRUS RNA;

ADULT; ANATOMICAL VARIATION; ARTICLE; BASAL GANGLION; BRAIN CORTEX; BRAIN EDEMA; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FEMALE; GRAY MATTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRON METABOLISM; MALE; MILD COGNITIVE IMPAIRMENT; MULTICONTRAST MAGNETIC RESONANCE IMAGING; NEUROANATOMY; NEUROIMAGING; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CODING; SUSCEPTIBILITY WEIGHTED IMAGING; THALAMUS; VIRUS LOAD; WHITE MATTER;

ADULT; ANTI-HIV AGENTS; BASAL GANGLIA; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DISCRIMINANT ANALYSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; RNA, VIRAL; THALAMUS;

EID: 84883790040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0072547     Document Type: Article

References (48)

1. Kaul M, Garden GA, Lipton SA, (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410: 988-994.
2. Power C, Gill MJ, Johnson RT, (2002) Progress in clinical neurosciences: The neuropathogenesis of HIV infection: host-virus interaction and the impact of therapy. Can J Neurol Sci 29: 19-32.
3. Navia BA, Cho ES, Petito CK, Price RW, (1986) The AIDS dementia complex: II. Neuropathology. Ann Neurol 19: 525-535.
4. Bell JE, (2004) An update on the neuropathology of HIV in the HAART era. Histopathology 45: 549-559.
5. McArthur JC, Steiner J, Sacktor N, Nath A, (2010) Human immunodeficiency virus-associated neurocognitive disorders: Mind the gap. Ann Neurol 67: 699-714.
6. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, et al. (2008) Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65-70.
7. Robertson KR, Su Z, Margolis DM, Krambrink A, Havlir DV, et al. (2010) Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort. Neurology 74: 1260-1266.
8. Ciccarelli N, Fabbiani M, Di Giambenedetto S, Fanti I, Baldonero E, et al. (2011) Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients. Neurology 76: 1403-1409.
9. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, et al. (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
10. Amariglio RE, Townsend MK, Grodstein F, Sperling RA, Rentz DM, (2011) Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc 59: 1612-1617.
11. Simioni S, Cavassini M, Annoni JM, Rimbault Abraham A, Bourquin I, et al. (2010) Cognitive dysfunction in HIV patients despite long-standing suppression of viremia. AIDS 24: 1243-1250.
12. Zigmond AS, Snaith RP, (1984) The hospital anxiety and depression scale. Acta Psychiatr Scand 67: 361-370.
13. Jack CR Jr, Bernstein MA, Borowski BJ, Gunter JL, Fox NC, et al. (2010) Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement 6: 212-220.
14. Marques JP, Kober T, Krueger G, van der Zwaag W, Van de Moortele PF, et al. (2010) MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage 49: 1271-1281.
15. Helms G, Dathe H, Kallenberg K, Dechent P, (2008) High-resolution maps of magnetization transfer with inherent correction for RF inhomogeneity and T1 relaxation obtained from 3D FLASH MRI. Magn Reson Med 60: 1396-1407.
16. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC, (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30: 19-30.
17. Henkelman RM, Stanisz GJ, Graham SJ, (2001) Magnetization transfer in MRI: a review. NMR Biomed 14: 57-64.
18. Levitt MH (2008) Spin Dynamics: Basics of Nuclear Magnetic Resonance (2nd edition); Sons JW, editor. New York.
19. Deoni SC, (2010) Quantitative relaxometry of the brain. Top Magn Reson Imaging 21: 101-113.
20. Schweser F, Sommer K, Deistung A, Reichenbach JR, (2012) Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 62: 2083-2100.
21. Roche A, Ribes D, Bach-Cuadra M, Kruger G, (2011) On the convergence of EM-like algorithms for image segmentation using Markov random fields. Med Image Anal 15: 830-839.
22. Klein S, Staring M, Murphy K, Viergever MA, Pluim JP, (2010) elastix: a toolbox for intensity-based medical image registration. IEEE Trans Med Imaging 29: 196-205.
23. Studholme C, Hill DLG, Hawkes DJ, (1998) An overlap invariant entropy measure of 3D medical image alignment. Pattern Recognition 1: 71-86.
24. Hermosillo G, Chefd'Hotel C, Faugeras O, (2002) Variational Methods for Multimodal Image Matching. International Journal of Computer Vision 50: 329-243.
25. Abdi H, editor (2007) Discriminant correspondence analysis. Thousand Oaks (CA). 270-275 p.
26. Henkelman RM, Huang X, Xiang QS, Stanisz GJ, Swanson SD, et al. (1993) Quantitative interpretation of magnetization transfer. Magn Reson Med 29: 759-766.
27. Schmierer K, Scaravilli F, Altmann DR, Barker GJ, Miller DH, (2004) Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol 56: 407-415.
28. Appay V, Sauce D, (2008) Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol 214: 231-241.
29. Kreis R Ernst T, Ross BD (1993) Absolute Quantification of Water and Metabolites in the Human Brain. II. Metabolite Concentrations. Journal of Magnetic Resonance: 9-19.
30. Kumar AM, Borodowsky I, Fernandez B, Gonzalez L, Kumar M, (2007) Human immunodeficiency virus type 1 RNA Levels in different regions of human brain: quantification using real-time reverse transcriptase-polymerase chain reaction. J Neurovirol 13: 210-224.
31. Kallianpur KJ, Kirk GR, Sailasuta N, Valcour V, Shiramizu B,et al. (2011) Regional Cortical Thinning Associated with Detectable Levels of HIV DNA. Cereb Cortex.
32. Thompson PM, Dutton RA, Hayashi KM, Toga AW, Lopez OL, et al. (2005) Thinning of the cerebral cortex visualized in HIV/AIDS reflects CD4+ T lymphocyte decline. Proc Natl Acad Sci U S A 102: 15647-15652.
33. Cardenas VA, Meyerhoff DJ, Studholme C, Kornak J, Rothlind J, et al. (2009) Evidence for ongoing brain injury in human immunodeficiency virus-positive patients treated with antiretroviral therapy. J Neurovirol 15: 324-333.
34. Bhatia R, Ryscavage P, Taiwo B (2011) Accelerated aging and human immunodeficiency virus infection: Emerging challenges of growing older in the era of successful antiretroviral therapy. J Neurovirol.
35. Chang L, Wong V, Nakama H, Watters M, Ramones D, et al. (2008) Greater than age-related changes in brain diffusion of HIV patients after 1 year. J Neuroimmune Pharmacol 3: 265-274.
36. McArthur JC, Brew BJ, Nath A, (2005) Neurological complications of HIV infection. Lancet Neurol 4: 543-555.
37. Elliott R, (2003) Executive functions and their disorders. Br Med Bull 65: 49-59.
38. Dahlin E, Neely AS, Larsson A, Backman L, Nyberg L, (2008) Transfer of learning after updating training mediated by the striatum. Science 320: 1510-1512.
39. Everall I, Vaida F, Khanlou N, Lazzaretto D, Achim C, et al. (2009) Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy. J Neurovirol 15: 360-370.
40. Anthony IC, Ramage SN, Carnie FW, Simmonds P, Bell JE, (2005) Influence of HAART on HIV-related CNS disease and neuroinflammation. J Neuropathol Exp Neurol 64: 529-536.
41. Holt JL, Kraft-Terry SD, Chang L, (2012) Neuroimaging studies of the aging HIV-1-infected brain. J Neurovirol 18: 291-302.
42. Simioni S, Cavassini M, Annoni J-M, Métral M, Iglesias K,et al. (2012) Rivastigmine for HIV-associated neurocognitive disorders: a randomized crossover pilot study; in pressNeurology.
43. Sahakian BJ, Owen AM, (1992) Computerized assessment in neuropsychiatry using CANTAB: discussion paper. J R Soc Med 85: 399-402.
44. Wechsler D (1981) Wechsler adult intelligence scale: revised [manual]. New York, USA: Psychological Corporation.
45. Reitan RM, Wolfson D (1993) The Hastead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson, Arizona, USA: Neuropsychology Press.
46. Rosen WG, Mohs RC, Davis KL, (1984) A new rating scale for Alzheimer's disease. Am J Psychiatry 141: 1356-1364.
47. Power C, Selnes OA, Grim JA, McArthur JC, (1995) HIV Dementia Scale: a rapid screening test. J Acquir Immune Defic Syndr Hum Retrovirol 8: 273-278.
48. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, et al. (2001) HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998. Neurology 56: 257-260.